Astrana Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Astrana Health, Inc. (ASTH) on March 30, 2026. The filing serves to provide interim unaudited financial statements regarding a previously completed acquisition and pro forma financial information.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it references the following documents filed as exhibits which contain the detailed data:
- Exhibit 99.1: Unaudited financial statements of the Acquired Business for the nine months ended June 30, 2025, and June 30, 2024.
- Exhibit 99.2: Unaudited Pro Forma Condensed Combined Statement of Operations for the fiscal year ended December 31, 2025.
Material Changes and Transaction Details
The primary event reported is the completion of the acquisition of the "Acquired Business," which includes:
- Prospect Health Plan, Inc.
- Alta Newport Hospital, LLC (d/b/a Foothill Regional Medical Center).
- Substantially all assets of certain direct and indirect subsidiaries of PHP Holdings, LLC.
The transaction was consummated on July 2, 2025, pursuant to an Asset and Equity Purchase Agreement dated November 8, 2024. The pro forma financial information presents the Company's operations as if the transaction had been consummated on January 1, 2025.
Guidance, Outlook, and Risks
Management explicitly states that the Unaudited Pro Forma Statement of Operations is for illustrative purposes only. It is not intended to represent or be indicative of the Company's actual consolidated results of operations that would have been reported had the transaction been completed on the presented date, nor does it represent future consolidated results. The pro forma adjustments are based on available information and management's reasonable assumptions.
Investor Verification Checklist
- Review Exhibit 99.1 for the specific financial performance of the Acquired Business for the nine months ended June 30, 2025.
- Analyze Exhibit 99.2 to understand the pro forma impact of the acquisition on the Company's fiscal year 2025 operations.
- Consult the original Form 8-K filed on July 2, 2025, and the amended Form 8-K/A filed on September 11, 2025, for a complete description of the Transaction terms.
- Verify the assumptions used in the pro forma adjustments, as these are not detailed in the cover page text.